AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 159 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 9.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $176,000 | -40.1% | 11,013 | -33.2% | 0.02% | -44.4% |
| Q1 2021 | $294,000 | +90.9% | 16,476 | +44.9% | 0.03% | +68.8% |
| Q4 2020 | $154,000 | -61.7% | 11,373 | -31.6% | 0.02% | -33.3% |
| Q4 2019 | $402,000 | -9.3% | 16,626 | +10.8% | 0.02% | -40.0% |
| Q2 2019 | $443,000 | +21.4% | 15,005 | +177.8% | 0.04% | +60.0% |
| Q2 2018 | $365,000 | -77.2% | 5,401 | -81.7% | 0.02% | -77.7% |
| Q1 2018 | $1,601,000 | +553.5% | 29,516 | +621.0% | 0.11% | +314.8% |
| Q4 2017 | $245,000 | -39.5% | 4,094 | -46.8% | 0.03% | -75.7% |
| Q2 2017 | $405,000 | +1.2% | 7,700 | -27.1% | 0.11% | +76.2% |
| Q4 2016 | $400,000 | +56.9% | 10,566 | +56.6% | 0.06% | +10.5% |
| Q3 2016 | $255,000 | -54.5% | 6,745 | -78.6% | 0.06% | +18.8% |
| Q3 2015 | $560,000 | -11.0% | 31,570 | +57.1% | 0.05% | -25.0% |
| Q1 2015 | $629,000 | – | 20,100 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |